MedPath

Effectiveness Of Natrum Muriaticum In Reducing Symptoms Of Depressive Episode

Phase 3
Registration Number
CTRI/2022/03/040888
Lead Sponsor
Dr ASWATHY B A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Cases satisfying Depressive episode diagnostic criteria of ICD10 Diagnostic Criteria for Research.

Age group between 18 to 60 years.

The cases in which Natrum Muriaticum comes up within the first five position according to repertorization result

Recurrent depressive episode

Exclusion Criteria

Depressive patients with severe suicidal ideation, with a history of attempted suicide

Mood disturbances when associated with schizophrenia, schizophreniform disorder, schizoaffective disorder or psychotic disorder otherwise specified

Any other conditions requiring emergency or surgical intervention

Subjects who are pregnant or lactating.

Severe systemic illness using conventional treatment.

Bipolar affective disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath